Cocrystal Historical Balance Sheet

COCP Stock  USD 1.88  0.10  5.05%   
Trend analysis of Cocrystal Pharma balance sheet accounts such as Total Current Liabilities of 2.7 M, Total Stockholder Equity of 42.6 M or Accounts Payable of 931.8 K provides information on Cocrystal Pharma's total assets, liabilities, and equity, which is the actual value of Cocrystal Pharma to its prevalent stockholders. By breaking down trends over time using Cocrystal Pharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cocrystal Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cocrystal Pharma is a good buy for the upcoming year.

Cocrystal Pharma Inventory

64,125

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.

About Cocrystal Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cocrystal Pharma at a specified time, usually calculated after every quarter, six months, or one year. Cocrystal Pharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cocrystal Pharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cocrystal currently owns. An asset can also be divided into two categories, current and non-current.

Cocrystal Pharma Balance Sheet Chart

At this time, Cocrystal Pharma's Total Current Assets are relatively stable compared to the past year. As of 12/11/2024, Other Current Liabilities is likely to grow to about 1.7 M, though Net Debt is likely to grow to (23.3 M).

Total Assets

Total assets refers to the total amount of Cocrystal Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cocrystal Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cocrystal Pharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cocrystal Pharma are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Cocrystal Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cocrystal Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most accounts from Cocrystal Pharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Total Current Assets are relatively stable compared to the past year. As of 12/11/2024, Other Current Liabilities is likely to grow to about 1.7 M, though Net Debt is likely to grow to (23.3 M).
 2021 2022 2023 2024 (projected)
Total Current Liabilities1.5M1.2M3.3M2.7M
Total Assets79.4M40.8M31.3M29.7M

Cocrystal Pharma balance sheet Correlations

0.170.580.030.20.24-0.080.98-0.41-0.060.55-0.09-0.160.77-0.10.570.3-0.44-0.28-0.46-0.43-0.140.680.41-0.450.34
0.17-0.320.430.60.04-0.410.240.05-0.40.11-0.37-0.650.45-0.350.140.860.180.480.010.16-0.360.290.770.120.84
0.58-0.32-0.21-0.220.50.170.53-0.670.160.680.140.53-0.060.130.68-0.23-0.38-0.26-0.32-0.510.120.5-0.26-0.51-0.31
0.030.43-0.210.750.05-0.990.24-0.14-0.990.09-0.8-0.650.19-0.990.130.280.05-0.1-0.330.480.330.330.260.440.45
0.20.6-0.220.75-0.08-0.750.35-0.11-0.740.13-0.51-0.90.39-0.740.230.47-0.04-0.06-0.40.6-0.170.310.470.60.76
0.240.040.50.05-0.08-0.020.24-0.34-0.020.41-0.040.28-0.08-0.040.39-0.20.34-0.310.24-0.01-0.06-0.04-0.33-0.05-0.22
-0.08-0.410.17-0.99-0.75-0.02-0.290.171.0-0.120.80.65-0.221.0-0.17-0.30.060.070.43-0.42-0.31-0.4-0.31-0.38-0.47
0.980.240.530.240.350.24-0.29-0.43-0.270.55-0.25-0.290.78-0.310.590.34-0.44-0.3-0.53-0.32-0.070.730.45-0.350.42
-0.410.05-0.67-0.14-0.11-0.340.17-0.430.17-0.960.18-0.170.020.18-0.960.020.240.10.30.16-0.28-0.430.090.190.03
-0.06-0.40.16-0.99-0.74-0.021.0-0.270.17-0.120.80.64-0.191.0-0.17-0.290.060.070.42-0.42-0.32-0.4-0.29-0.39-0.46
0.550.110.680.090.130.41-0.120.55-0.96-0.12-0.190.120.15-0.130.980.15-0.23-0.04-0.25-0.230.110.460.07-0.270.11
-0.09-0.370.14-0.8-0.51-0.040.8-0.250.180.8-0.190.46-0.220.78-0.15-0.30.01-0.110.15-0.34-0.4-0.24-0.27-0.28-0.41
-0.16-0.650.53-0.65-0.90.280.65-0.29-0.170.640.120.46-0.590.640.04-0.56-0.020.00.28-0.560.24-0.18-0.62-0.55-0.83
0.770.45-0.060.190.39-0.08-0.220.780.02-0.190.15-0.22-0.59-0.210.170.55-0.22-0.15-0.29-0.14-0.260.430.7-0.170.65
-0.1-0.350.13-0.99-0.74-0.041.0-0.310.181.0-0.130.780.64-0.21-0.18-0.250.080.140.45-0.42-0.31-0.41-0.26-0.39-0.44
0.570.140.680.130.230.39-0.170.59-0.96-0.170.98-0.150.040.17-0.180.16-0.28-0.07-0.36-0.20.060.530.1-0.230.17
0.30.86-0.230.280.47-0.2-0.30.340.02-0.290.15-0.3-0.560.55-0.250.16-0.250.65-0.27-0.14-0.40.50.96-0.190.91
-0.440.18-0.380.05-0.040.340.06-0.440.240.06-0.230.01-0.02-0.220.08-0.28-0.25-0.20.870.540.08-0.67-0.380.51-0.23
-0.280.48-0.26-0.1-0.06-0.310.07-0.30.10.07-0.04-0.110.0-0.150.14-0.070.65-0.20.0-0.26-0.190.120.54-0.280.41
-0.460.01-0.32-0.33-0.40.240.43-0.530.30.42-0.250.150.28-0.290.45-0.36-0.270.870.00.280.04-0.76-0.40.23-0.36
-0.430.16-0.510.480.6-0.01-0.42-0.320.16-0.42-0.23-0.34-0.56-0.14-0.42-0.2-0.140.54-0.260.280.03-0.51-0.20.980.17
-0.14-0.360.120.33-0.17-0.06-0.31-0.07-0.28-0.320.11-0.40.24-0.26-0.310.06-0.40.08-0.190.040.030.02-0.38-0.02-0.43
0.680.290.50.330.31-0.04-0.40.73-0.43-0.40.46-0.24-0.180.43-0.410.530.5-0.670.12-0.76-0.510.020.55-0.510.42
0.410.77-0.260.260.47-0.33-0.310.450.09-0.290.07-0.27-0.620.7-0.260.10.96-0.380.54-0.4-0.2-0.380.55-0.230.91
-0.450.12-0.510.440.6-0.05-0.38-0.350.19-0.39-0.27-0.28-0.55-0.17-0.39-0.23-0.190.51-0.280.230.98-0.02-0.51-0.230.14
0.340.84-0.310.450.76-0.22-0.470.420.03-0.460.11-0.41-0.830.65-0.440.170.91-0.230.41-0.360.17-0.430.420.910.14
Click cells to compare fundamentals

Cocrystal Pharma Account Relationship Matchups

Cocrystal Pharma balance sheet Accounts

201920202021202220232024 (projected)
Total Assets28.5M54.2M79.4M40.8M31.3M29.7M
Total Current Liabilities2.3M1.4M1.5M1.2M3.3M2.7M
Total Stockholder Equity25.7M52.5M77.5M39.6M26.4M42.6M
Net Debt(6.6M)(32.4M)(58.2M)(36.8M)(24.5M)(23.3M)
Retained Earnings(235.3M)(244.9M)(259.1M)(297.9M)(315.9M)(300.1M)
Accounts Payable1.5M657K578K614K1.2M931.8K
Cash7.4M33.0M58.7M37.1M26.4M27.7M
Non Current Assets Total20.3M20.2M20.1M662K2.2M2.1M
Non Currrent Assets Other(293K)40K50K46K52.9K55.5K
Cash And Short Term Investments7.4M33.0M58.7M37.1M26.4M27.7M
Common Stock Total Equity24K30K36K71K81.7K152.4K
Common Stock Shares Outstanding31.9M55.2M88.4M8.1M9.7M13.1M
Liabilities And Stockholders Equity28.5M54.2M79.4M40.8M31.3M29.7M
Other Stockholder Equity260.9M297.3M336.5M337.5M342.3M359.4M
Total Liab2.8M1.7M1.8M1.3M4.9M4.6M
Total Current Assets8.3M34.0M59.3M40.2M29.1M30.5M
Common Stock36K71K98K8K10K9.5K
Other Current Liab7K267K495K122K1.6M1.7M
Property Plant And Equipment Net1.1M1.1M931K616K2.1M2.2M
Other Current Assets169K449K618K2.3M1.8M948.7K
Property Plant And Equipment Gross1.1M1.1M2.4M2.2M3.9M4.1M
Short Long Term Debt Total817K596K534K297K1.9M1.6M
Non Current Liabilities Total537K379K298K57K1.6M1.5M
Short Term Debt280K434K472K480K432K410.4K
Net Tangible Assets6.6M33.4M58.5M39.6M35.6M34.6M
Other Assets50K544K46K0.01.00.95
Retained Earnings Total Equity(138.0M)(187.1M)(235.3M)(244.9M)(220.4M)(209.4M)
Capital Surpluse243.4M253.9M260.9M297.3M341.9M215.9M
Property Plant Equipment1.1M1.1M931K616K708.4K640.6K
Net Invested Capital25.7M52.5M77.5M39.6M26.4M45.1M

Pair Trading with Cocrystal Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cocrystal Stock

  0.61BMY Bristol Myers SquibbPairCorr

Moving against Cocrystal Stock

  0.64AMGN Amgen IncPairCorr
  0.63ABBV AbbVie IncPairCorr
  0.6TTOO T2 BiosystmsPairCorr
  0.58PFE Pfizer Inc Fiscal Year End 4th of February 2025 PairCorr
  0.57MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Cocrystal Stock Analysis

When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.